Cheung et al.10presented adequate genomic data certifying the amplification of CRKL gene at 22q11.21 in NSCLC and high expression of CRKL induces lung cancer cells with EGFR mutations resistant to EGFR inhibitors through regulating AKT and MAPK pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.